UNSPSC 51431608: Terodiline

This classification denotes a calcium channel blocker and parasympatholytic with the molecular formula C20H27N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70KG06964W, chemically known as propylamine, n-tert-butyl-1-methyl-3,3-diphenyl- but generally known as terodiline, which bears US NIH Compound Identifier 23480. European Medicines Agency schedules Terodiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10929MIG.

UNSPSC 51431608 Terodiline is a Commodity code that encompasses emergency and acute-care pharmaceutical products supplied to state and local government health systems, fire rescue services, and pharmacy benefit programs. State and local governments procure under this code specific injectable medications and other therapeutic agents required by emergency medical services, hospitals, and centralized pharmaceutical distribution networks. The issuing bodies soliciting under the code span city fire rescue departments, state health agencies, and multistate cooperative purchasing alliances coordinating acquisitions across member jurisdictions. Work being solicited includes direct supply of individual medication units with strict expiration-date management, participation in statewide pharmaceutical cooperative contracts through authorized wholesalers, and exploratory vendor engagement for direct-to-manufacturer prescription fulfillment models that bypass traditional pharmacy benefit managers and group purchasing organizations.

Recent activity reflects purchases across Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (four specific injectable lines totaling approximately 3,530 units) to supply Tampa Fire Rescue, with sealed bids due April 8, 2026, under a SLBE sheltered-market designation offering a 5 percent bid discount not to exceed $10,000, estimated contract value $40,000 and a one-year term with two optional renewals. The Texas Health and Human Services Commission posted RFI HHS0017013 on March 27, 2026, deadline April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs serving self-insured state employee and retiree plans. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers across participating state and local facilities including Oregon, with proposals due March 26, 2026, contract term two years effective July 1, 2026, evaluated primarily on price competitiveness (75 percent) and fixed pricing, administrative compliance, EDI capability, and fee structure (25 percent combined).